Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Valenciennes
Clinical trial register · France

Clinical Trials in Valenciennes, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9729 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:18 UTC
9729
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1030
Lead sponsors
across recruiting studies
Top sites
Paris 2848 Lyon 1397 Bordeaux 1393 Marseille 1290 Lille 1276
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Centre Hospitalier de Valenciennes8 Merck Sharp & Dohme LLC4 University Hospital, Lille4 Novartis Pharmaceuticals3 Shunmei Medical1 Centre Oscar Lambret1 Novo Nordisk A/S1 Sheffield Teaching Hospitals NHS Foundation Trust1 Bristol-Myers Squibb1 Stemline Therapeutics, Inc.1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 AbbVie1 Centre Hospitalier Universitaire, Amiens1 Ionis Pharmaceuticals, Inc.1 Applied Therapeutics, Inc.1 University Hospital, Rouen1 Cytokinetics1 Amgen1 Centre Georges Francois Leclerc1
Site location
Paris2848 Lyon1397 Bordeaux1393 Marseille1290 Lille1276 Montpellier1014 Toulouse1011 Nantes912 Dijon813 Angers773 Nice771 Clermont-Ferrand750 Caen727 Brest726 Strasbourg674 Amiens622 Villejuif570 Créteil559 Besançon553 Bron551 Rennes537 Grenoble514 Rouen388 Poitiers349 Pierre-Bénite344 Show all 805
All 805 locations
Target enrolment
to

Trials with a site in Valenciennes

34 of 9729 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer
NCT06726330Tubo-ovarian Carcinoma, High-grade Serous Carcinoma, Primary Peritoneal Carcinoma Stage III, Primary Peritoneal Carcinoma Stage IV
Centre Oscar Lambret
Not applicable
1,100
Lyon, Toulouse, Valenciennes, Bordeaux, Caen, Clermont-Ferrand, Dijon, Grenoble
2027-03
Not yet open
Centre Hospitalier de Valenciennes
Not applicable
75
Valenciennes
2026-12
Not yet open
Centre Hospitalier de Valenciennes
Not applicable
216
Valenciennes
2026-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
310
Pessac, Valenciennes
2026-06-18
Recruiting
ShockFast Intravascular Lithotripsy Device for Treatment of Calcified Coronary Lesions
NCT07407738Coronary Arterial Disease, Calcified Coronary Artery Disease
Shunmei Medical
Not applicable
120
Lyon, Paris, Valenciennes
2026-02-16
Recruiting
Pilot Study on the Use of Video Laryngoscopy in Pre-hospital Settings
NCT07630467Emergency, Orotracheal Intubation
Centre Hospitalier de Valenciennes
Not applicable
143
Valenciennes
2026-01-02
Recruiting
SpaceOAR Post-Market Registry Study
NCT07300631Prostate Cancer Patients Treated by Radiotherapy
Sheffield Teaching Hospitals NHS Foundation Trust
Observational
320
Brest, Toulouse, Valenciennes
2025-12-31
Recruiting
Centre Hospitalier de Valenciennes
Observational
984
Valenciennes
2025-12-02
Active, closed
Multicentre Real-life Data Collection Study With CareMin650™ in the Prevention and Treatment of Oral Mucositis and Radio- and/or Chemo-induced Dermatitis
NCT07054528Oral Mucositis (Ulcerative), Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy, Oral Mucositis (Ulcerative) Due to Radiation, Dermatitis
Centre Hospitalier de Valenciennes
Observational
33,000
Valenciennes
2025-06-20
Recruiting
Centre Hospitalier de Valenciennes
Not applicable
200
Valenciennes
2025-06-13
Recruiting
Cytokinetics
Phase 3
1,800
Toulouse, Valenciennes, Rennes, La Tronche, Montpellier, Nantes, Bron, Toulon
2024-12-19
Active, closed
Stemline Therapeutics, Inc.
Phase 3
4,556
Strasbourg, Grenoble, Valenciennes, Montpellier, Chambray-lès-Tours, Limoges, La Chaussée-Saint-Victor, Saint-Herblain
2024-09-27
Recruiting
University Hospital, Rouen
Not applicable
184
Valenciennes, Caen, Rouen
2024-09-09
Active, closed
Amgen
Phase 3
315
Bordeaux, Limoges, Marseille, Montpellier, Nîmes, Toulon, Valenciennes, Vantoux
2024-09-09
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Bordeaux, Créteil, Le Puy-en-Velay, Marseille, Nantes, Paris, Saint-Priest-en-Jarez, Valenciennes
2024-08-30
Recruiting
University Hospital, Lille
Observational
139
Valenciennes
2024-06-11
Recruiting
Centre Hospitalier de Valenciennes
Not applicable
192
Valenciennes
2024-05-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Nice, Dijon, Quimper, Nîmes, Valenciennes, Clermont-Ferrand, Avignon, Boulogne-Billancourt
2024-05-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
Brest, Toulouse, Rouen, Limoges, Valenciennes, Clermont-Ferrand, Bron, Toulon
2024-04-03
Active, closed
Novo Nordisk A/S
Phase 3
673
Chambray-lès-Tours, Poitiers, Rennes, Rouen, Toulon, Valenciennes, Vandœuvre-lès-Nancy
2024-04-01
Recruiting
Centre Hospitalier de Valenciennes
Not applicable
289
Valenciennes
2023-12-12
Active, closed
Novartis Pharmaceuticals
Observational
1,019
Nice, Marseille, Dijon, Saint-Denis, Valenciennes, Saint-Cloud, Grenoble, Reims
2022-12-13
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
Bron, Dijon, Marseille, Montpellier, Paris, Saint-Herblain, Strasbourg, Valenciennes
2022-12-13
Active, closed
Novartis Pharmaceuticals
Phase 3
210
Besançon, Clermont-Ferrand, La Roche-sur-Yon, Lyon, Marseille, Montpellier, Paris, Valenciennes
2021-12-17
Recruiting
A Case Management Algorithm for Women Victims of Violence
NCT04953273Post-Traumatic Stress Disorder, Violence-Related Symptom
University Hospital, Lille
Not applicable
756
Amiens, Boulogne-sur-Mer, Caen, Creil, Lille, Rouen, Saint-Quentin, Valenciennes
2021-07-06
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
DrugsAtrasentan·Zigakibart
Novartis Pharmaceuticals
Phase 3
404
Grenoble, Le Puy-en-Velay, Paris, Saint-Priest-en-Jarez, Valenciennes
2020-12-11
Active, closed
Centre Hospitalier Universitaire, Amiens
Phase 2
74
Abbeville, Amiens, Compiègne, Rang-du-Fliers, Saint-Quentin, Tourcoing, Valenciennes
2020-09-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Marseille, Brest, Epagny Metz Tessy, Valenciennes, Bobigny, Amiens, Toulon, La Roche-sur-Yon
2020-07-06
Active, closed
Applied Therapeutics, Inc.
Phase 3
675
Bondy, Créteil, Nantes, Valenciennes
2019-09-20
Active, closed
Bristol-Myers Squibb
Phase 3
437
Nice, Brest, Nancy, Valenciennes, Angers, Besançon, Caen, Hyères
2019-06-21
Recruiting
University Hospital, Lille
Not applicable
396
Amiens, Boulogne-sur-Mer, Lille, Valenciennes
2019-06-16
Recruiting
Determinants of the Long-Term Success of Bariatric Surgery
NCT03517072Morbid Obesity, Bariatric Surgery Candidate
University Hospital, Lille
Observational
1,000
Arras, Boulogne-sur-Mer, Lille, Valenciennes
2018-07-31
Active, closed
AbbVie
Phase 3
747
Nice, Pessac, Toulouse, Montpellier, La Tronche, Vandœuvre-lès-Nancy, Lille, Valenciennes
2018-03-21
Active, closed
Centre Georges Francois Leclerc
Not applicable
67
Amiens, Besançon, Dijon, Mâcon, Nancy, Strasbourg, Valenciennes
2017-04-07
Rows per page Showing 1–34 of 34
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-france/city/valenciennes

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,729 studies in total at the last sync on 14 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 34 of those studies with a site in Valenciennes.

How many clinical trials are recruiting in Valenciennes?

16 of the 34 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:18 UTC sync. A further 3 have not yet opened recruitment, 15 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Valenciennes), 34 studies
PhaseStudiesRecruitingShare
Phase 315444.1%
Not applicable12835.3%
Observational6417.6%
Phase 2102.9%

Most active sponsors

Lead sponsors with the most studies (Valenciennes)
Lead sponsorStudiesRecruiting
Centre Hospitalier de Valenciennes85
Merck Sharp & Dohme LLC43
University Hospital, Lille44
Novartis Pharmaceuticals30
AbbVie10
Alpine Immune Sciences Inc, A Subsidiary of Vertex10
Amgen10
Applied Therapeutics, Inc.10
Bristol-Myers Squibb10
Centre Georges Francois Leclerc10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.